CRP: Search Results

Your Search Currently Includes:
	Project Type	=	Clinical Trial
	Year	=	Currently Active
	Type of Research	=	Treatment
	Type of Cancer	=	Breast Cancer

Add Criteria to Narrow Your Search

To save items to a common list, check each desired
item, then click the Add to My List button.


[1-25 of 112]	[Next 25]	[Show All]

#	Title Sort	Principal Investigator Sort	State Sort	Institution Sort	Fund Mech, Sort Project ID Sort
1.	Clinical Trial - Phase II Study of BMS-247550 in Patients With Incurable, Locally Advanced or Metastatic Breast Cancer
2.	Clinical Trial - Phase II Randomized Study of Celecoxib in Women With Metastatic or Recurrent Breast Cancer
3.	Clinical Trial - Phase II Study of Tipifarnib, Doxorubicin, and Cyclophosphamide in Women With Locally Advanced Breast Cancer
4.	Clinical Trial - Phase I Study of Thalidomide and Docetaxel in Patients With Advanced Malignancies
5.	Clinical Trial - Phase I Study of Gemcitabine and Mistletoe in Patients With Advanced Solid Tumors
6.	Clinical Trial - Phase II Study of Tipifarnib and Tamoxifen in Women With Hormone Receptor-Positive Metastatic Breast Cancer
7.	Clinical Trial - Phase II Study of GW572016 in Women With Advanced or Metastatic Breast Cancer Refractory to First-Line Trastuzumab (Herceptin) and Chemotherapy
8.	Clinical Trial - Phase I/II Study of Vaccinia-CEA-TRICOM Vaccine Before Dose-Intensive Induction Chemotherapy and Fowlpox-CEA-TRICOM Vaccine After Dose-Intensive Induction Chemotherapy and Immune Depletion in Patients With Previously Untreated Metastatic Breast Cancer
9.	Clinical Trial - Phase III Randomized Study of Anastrozole Versus Tamoxifen in Postmenopausal Women With Ductal Carcinoma in Situ of the Breast Undergoing Lumpectomy and Radiotherapy
10.	Clinical Trial - Phase I/II Study of Low-Dose Suramin and Paclitaxel in Women With Stage IIIB or IV Breast Cancer
11.	Clinical Trial - Phase II Study of Erlotinib and Bevacizumab in Women With Previously Treated Stage IV Breast Cancer
12.	Clinical Trial - Phase II Study of Perifosine in Patients With Recurrent or Refractory, Locally Advanced or Metastatic Breast Cancer
13.	Clinical Trial - Phase II Study of Erlotinib and Docetaxel in Patients With Stage IV or Recurrent Breast Cancer
14.	Clinical Trial - Phase I Study of CP-724,714 in Patients With Metastatic HER2-Overexpressing Breast Cancer
15.	Clinical Trial - Phase II Randomized Study of Anastrozole and Gefitinib Versus Fulvestrant and Gefitinib in Postmenopausal Women With Recurrent or Metastatic Hormone Receptor-Positive Breast Cancer
16.	Clinical Trial - Phase II Study of Trastuzumab (Herceptin) and Exemestane in Postmenopausal Women With Metastatic or Locally Advanced Hormone-Responsive, HER2/neu Positive Breast Cancer
17.	Clinical Trial - Phase II Study of Docetaxel in Older Patients With Metastatic Breast or Lung Cancer
18.	Clinical Trial - Phase II Study of High-Dose Chemotherapy, Total Body Irradiation, and Autologous Peripheral Blood or Bone Marrow Transplantation in Patients With Hematologic Malignancies or Selected Chemosensitive Solid Tumors
19.	Clinical Trial - Phase I Study of Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody (MDX-010) After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Persistent or Progressive Malignancies
20.	Clinical Trial - Phase I/II Study of Oblimersen in Combination With Doxorubicin and Docetaxel in Patients With Metastatic or Locally Advanced Breast Cancer
21.	Clinical Trial - Phase I Study of Intrapleural BG00001 in Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
22.	Clinical Trial - Phase I/II Study of Three-Dimensional Conformal Radiotherapy In Women With Stage I or II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection
23.	Clinical Trial - Phase I/II Study of Monoclonal Antibody HuHMFG1 in Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane-Based Therapy
24.	Clinical Trial - Extension Study of Bevacizumab in Patients With Metastatic Breast or Colorectal Cancer Who Received Bevacizumab on a Genentech-Sponsored Phase II or III Trial
25.	Clinical Trial - Phase III Randomized Study of Ovarian Function Suppression in Combination With Tamoxifen Versus Ovarian Function Suppression in Combination With Exemestane Versus Tamoxifen Alone in Premenopausal Women With Endocrine-Responsive Breast Cancer

[1-25 of 112]

[Next 25]

[Show All]

Add Criteria to Narrow Your Search


Research Portfolio Home \| Dictionary \| Site Map \| Privacy Policy \| Accessibility \| Contact Us